Sale of IP or
Production engineering, manufacture and distribution of patented instrument for non-invasive Type 2 diabetes screening
|
Estimated $20 million per annum worldwide
|
Manufacture and sales into Asia and beyond subject to performance
Preference for companies familiar with medical instruments
|
Medium scale manufacture of optical science instruments.
Optical and signal processing expertise
Distribution and support
|
Glyvale Ltd
Contact:
Neville Jordan Chairman
+64 4 4995140
Email:
njordan@ecap.co.nz
|